[ad_1] 2 December 2020 Horizon Discovery Group plc, a global leader in applying gene editing and gene modulation to cell line engineering, today announced that it has granted two commercial licenses for its cGMP-compliant CHOSOURCE ™ platform to Sanyou Biopharmaceuticals Co., Ltd., a leading biotechnology company focused on the research, …
Read More »Protalix BioTherapeutics (PLX) – Bitcoin & Stock Journal
[ad_1] Protalix BioTherapeutics (PLX): In Thursday negotiation session Protalix BioTherapeutics (PLX) the price of the shares ended at $ 0.3 with a variation of 1.55%. The recent trading activity revealed that the share price fell to 11.89% from its minimum of 52 weeks and traded with a variation of -63.60% …
Read More »